BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 19142421)

  • 1. Quetiapine for the treatment of trichotillomania.
    Crescente Junior JA; Guzman CS; Tavares H
    Braz J Psychiatry; 2008 Dec; 30(4):402. PubMed ID: 19142421
    [No Abstract]   [Full Text] [Related]  

  • 2. Olanzapine augmentation of fluoxetine in the treatment of trichotillomania.
    Potenza MN; Wasylink S; Epperson CN; McDougle CJ
    Am J Psychiatry; 1998 Sep; 155(9):1299-300. PubMed ID: 9734562
    [No Abstract]   [Full Text] [Related]  

  • 3. An overview of trichotillomania and its response to treatment with quetiapine.
    Khouzam HR; Battista MA; Byers PE
    Psychiatry; 2002; 65(3):261-70. PubMed ID: 12405081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quetiapine plus SSRI in treatment-resistant depression: possible mechanisms.
    Devarajan S; Ali J; Dursun SM
    Psychopharmacology (Berl); 2006 Apr; 185(3):402-3. PubMed ID: 16538471
    [No Abstract]   [Full Text] [Related]  

  • 5. A double-blind, randomized, controlled trial of fluoxetine plus quetiapine or clomipramine versus fluoxetine plus placebo for obsessive-compulsive disorder.
    Diniz JB; Shavitt RG; Fossaluza V; Koran L; Pereira CA; Miguel EC
    J Clin Psychopharmacol; 2011 Dec; 31(6):763-8. PubMed ID: 22020357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trichotillomania: a treatment overview.
    Voth D
    J Pract Nurs; 2006 Winter-2007 Spring; 56(4)-57(1)():34-7. PubMed ID: 17484394
    [No Abstract]   [Full Text] [Related]  

  • 7. A case of problematic internet use successfully treated with an SSRI-antipsychotic combination.
    Atmaca M
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 May; 31(4):961-2. PubMed ID: 17321659
    [No Abstract]   [Full Text] [Related]  

  • 8. Quetiapine-fluvoxamine combination during pregnancy and while breastfeeding.
    Gentile S
    Arch Womens Ment Health; 2006 May; 9(3):158-9. PubMed ID: 16683078
    [No Abstract]   [Full Text] [Related]  

  • 9. Quetiapine addition in obsessive-compulsive disorder: is treatment outcome affected by type and dose of serotonin reuptake inhibitors?
    Denys D; Fineberg N; Carey PD; Stein DJ
    Biol Psychiatry; 2007 Feb; 61(3):412-4. PubMed ID: 17241831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quetiapine-induced weight gain and escitalopram.
    Holzer L; Paiva G; Halfon O
    Am J Psychiatry; 2005 Jan; 162(1):192-3. PubMed ID: 15625223
    [No Abstract]   [Full Text] [Related]  

  • 11. Adjunctive quetiapine for serotonin reuptake inhibitor-resistant obsessive-compulsive disorder: a meta-analysis of randomized controlled treatment trials.
    Fineberg NA; Stein DJ; Premkumar P; Carey P; Sivakumaran T; Vythilingum B; Seedat S; Westenberg H; Denys D
    Int Clin Psychopharmacol; 2006 Nov; 21(6):337-43. PubMed ID: 17012980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pooled analysis of adjunct extended-release quetiapine fumarate in patients with major depressive disorder according to ongoing SSRI or SNRI treatment.
    Bauer M; Demyttenaere K; El-Khalili N; Thase ME; Papakostas GI; Szamosi J; Earley WR; Eriksson H
    Int Clin Psychopharmacol; 2014 Jan; 29(1):16-25. PubMed ID: 24108148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Trichotillomania. Clinical case].
    Silva H
    Rev Med Chil; 1997 Apr; 125(4):457-9. PubMed ID: 9460288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quetiapine augmentation of serotonin reuptake inhibitors in obsessive-compulsive disorder.
    Mohr N; Vythilingum B; Emsley RA; Stein DJ
    Int Clin Psychopharmacol; 2002 Jan; 17(1):37-40. PubMed ID: 11800505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind, randomized, placebo-controlled trial of quetiapine addition in patients with obsessive-compulsive disorder refractory to serotonin reuptake inhibitors.
    Denys D; de Geus F; van Megen HJ; Westenberg HG
    J Clin Psychiatry; 2004 Aug; 65(8):1040-8. PubMed ID: 15323587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel treatment option of bipolar depression with psychotic and catatonic features.
    Di Michele V; Bolino F
    Gen Hosp Psychiatry; 2006; 28(4):364-5. PubMed ID: 16814640
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative efficacy and acceptability of drug treatments for bipolar depression: a multiple-treatments meta-analysis.
    Taylor DM; Cornelius V; Smith L; Young AH
    Acta Psychiatr Scand; 2014 Dec; 130(6):452-69. PubMed ID: 25283309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quetiapine addition to serotonin reuptake inhibitor treatment in patients with treatment-refractory obsessive-compulsive disorder: an open-label study.
    Denys D; van Megen H; Westenberg H
    J Clin Psychiatry; 2002 Aug; 63(8):700-3. PubMed ID: 12197450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute and maintenance treatments for bipolar depression.
    Ketter TA
    J Clin Psychiatry; 2014 Apr; 75(4):e10. PubMed ID: 24813411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quetiapine augmentation in obsessive-compulsive disorder resistant to serotonin reuptake inhibitors: an open-label study.
    Bogan AM; Koran LM; Chuong HW; Vapnik T; Bystritsky A
    J Clin Psychiatry; 2005 Jan; 66(1):73-9. PubMed ID: 15669891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.